Skip over left navigation and go straight to content

James B. Herrick Symposium - Sickle Cell Disease Care and Research: Past, Present, and Future

In 1910, Dr. James B. Herrick, an attending physician at Presbyterian Hospital and professor of medicine at Rush Medical College in Chicago, Illinois, published an article on the case of an anemic West Indian patient1. Herrick’s clinical and laboratory findings of the patient’s "peculiar elongated and sickle-shaped” red blood corpuscles represent the first description of sickle cell anemia in Western medical literature.

To mark the centennial of the publication of Herrick’s case report, the National Institutes of Health is pleased to announce the James B. Herrick Symposium - Sickle Cell Disease Care and Research: Past, Present and Future to be held on November 16-17, 2010, on the NIH campus in Bethesda, MD. National and international experts in sickle cell care and research will examine the history and societal impact of the disease and place the disease within the context of existing and future basic, translational and clinical research. Invited speakers will address unresolved challenges and the ongoing burden of the disease. They will also focus on genetic, cellular and clinical perspectives across the lifespan, as well as existing therapeutic options and possible future treatments.

An interdisciplinary audience of scientists, practitioners, academicians, members of the sickle cell community and the public is expected to participate in this commemorative symposium. Please join us.

Archives of Internal Medicine 6 (5): 517-211external link

Confirmed Speakers:

  • Robert J. Adams, M.D., Medical University of South Carolina
  • Sonja L. Banks, Sickle Cell Disease Association of America, Inc.
  • Mary Catherine Beach, M.D., M.P.H., Johns Hopkins University
  • Vence L. Bonham, Jr., J.D., National Human Genome Research Institute
  • George R. Buchanan, M.D., University of Texas Southwestern Medical Center at Dallas
  • H. Franklin Bunn, M.D., Brigham and Women’s Hospital/Harvard Medical School
  • Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health
  • Michael R. DeBaun, M.D., M.P.H., Vanderbilt School of Medicine
  • Duana Fullwiley, Ph.D., Harvard University
  • Frank Grosveld, Ph.D., Erasmus MC (The Netherlands)
  • Carlton Haywood, Jr., Ph.D., M.A., Johns Hopkins University School of Medicine
  • Robert P. Hebbel, M.D., University of Minnesota
  • J. Hoxi Jones, Texas Health and Human Services Commission
  • Lanetta B. Jordan, M.D., M.P.H., M.S.P.H., Sickle Cell Disease Association of America, Inc. and Memorial Healthcare
       System, Hollywood, FL
  • Sophie Lanzkron, M.D., Johns Hopkins University School of Medicine
  • Donald A.B. Lindberg, M.D., National Library of Medicine
  • Sebastian Lucas, FRCP, FRCPath, King's College London School of Medicine (United Kingdom)
  • Julie Makani, M.D., MRCP, Muhimbili University of Health and Allied Sciences (Tanzania)
  • Punam Malik, M.D., Cincinnati Children's Hospital Medical Center
  • John C. Morrison, M.D., University of Mississippi Medical Center
  • Robert Murray, M.D., Howard University Hospital
  • David Nathan, M.D., Dana-Farber Cancer Institute
  • Arthur W. Nienhuis, M.D., St. Jude Children's Research Hospital
  • Kwaku Ohene-Frempong, M.D., University of Pennsylvania School of Medicine/Children’s Hospital of Philadelphia
  • Stuart H. Orkin, M.D., Harvard Medical School/Dana-Farber Cancer Institute
  • Stephen Pemberton, Ph.D., New Jersey Institute of Technology
  • Griffin P. Rodgers, M.D., M.A.C.P., National Institute of Diabetes and Digestive and Kidney Diseases
  • Carolyn Rouse, Ph.D., Princeton University
  • Alan N. Schechter, M.D., National Institute of Diabetes and Digestive and Kidney Diseases
  • Graham R. Serjeant, M.D., FRCP, Sickle Cell Trust (Jamaica)
  • Susan B. Shurin, M.D., National Heart, Lung, and Blood Institute
  • Wally R. Smith, M.D., Virginia Commonwealth University
  • Swee Lay Thein, FRCPath., FRCP, D.Sc., F.Med.Sci., King’s College London (United Kingdom)
  • John F. Tisdale, M.D., National Heart, Lung, and Blood Institute
  • Tim M. Townes, Ph.D., University of Alabama at Birmingham
  • Elliott Vichinsky, M.D., Children’s Hospital and Research Center Oakland
  • Russell E. Ware, M.D., Ph.D., St. Jude Children’s Research Hospital
  • Sir David Weatherall, M.D., FRCP, FRS, University of Oxford (United Kingdom)
  • Wanda Whitten-Shurney, M.D., Children’s Hospital of Michigan
  • Clifford Woolf, M.D., Ph.D., Harvard Medical School
  • Barbara Yawn, M.D., M.Sc., University of Minnesota

Scientific Organizing Committee:

  • Chair: W. Keith Hoots, M.D., National Heart, Lung, and Blood Institute
  • Vence L. Bonham, Jr., J.D., National Human Genome Research Institute
  • Donna Dimichele, M.D., National Heart, Lung, and Blood Institute
  • Jonathan C. Goldsmith, M.D., National Heart, Lung, and Blood Institute
  • Stephen C. Groft, Pharm.D., Office of Rare Diseases Research
  • Liana Harvath, Ph.D., National Heart, Lung, and Blood Institute
  • Joyce A. Hunter, Ph.D., National Center on Minority Health and Health Disparities
  • Regina James, M.D., National Institute of Child Health and Human Development
  • Harvey Luksenburg, M.D., National Heart, Lung, and Blood Institute
  • Dever Powell, M.S.L.I.S., National Library of Medicine
  • Jeffrey S. Reznick, Ph.D., National Library of Medicine
  • Alan N. Schechter, M.D., National Institute on Diabetes and Digestive and Kidney Diseases
  • Susan B. Shurin, M.D., National Heart, Lung, and Blood Institute
  • Danilo A. Tagle, Ph.D., National Institute of Neurological Disorders and Stroke
  • Ellen M. Werner, Ph.D, National Heart, Lung, and Blood Institute
  • Daniel Wright, M.D., National Institute on Diabetes and Digestive and Kidney Diseases






Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon